Effect of Blue Laser Intranasal Irradiation on Hyperlipidemia in Patients with Coronary Atherosclerosis

This study was conducted to evaluate the effect of adding blue Laser (405nm) blood irradiation therapy to Statins therapy in managing hyperlipidemia in atherosclerotic patients. Forty patients were assigned randomly to two equal groups, with age ranged between 50-60 years. The study group received twelve intranasal blue laser irradiation sessions, 30 minutes each, besides Statins therapy, while the control group received only Statins therapy (10mg/day), all patients adhered to low-fat diet program. Lipid profiles for all patients were screened before, and immediately after one month of treatment. There was a significant improvement in lipid profile before and after treatment for each group, but there was no significant difference (p .015) between the study group and the control group. It was concluded that intranasal blue laser blood irradiation (405nm, 5mw, 30 minutes, 12 sessions) adds no extra benefits other than those gained by Statins therapy, while managing lipid profile in atherosclerotic patients.